|
Form Serial Number: |
DA20240125E00156
|
1.
Date of relevant event: |
24/01/2024 (dd/mm/yyyy)
|
2.
Date when director became aware of the relevant event/ interest in the shares (if later): |
(dd/mm/yyyy)
|
3.
Stock code: |
02269 |
4.
Name of listed corporation: |
WuXi Biologics (Cayman) Inc. |
5.
Class of shares: |
Ordinary Shares |
6.
Number of issued shares in class: |
4,258,313,066 |
7.
Name of director (English) as printed on HKID Card/Passport: |
(Surname) |
Li |
(Other names) |
Ge |
|
|
|
10.
Name of director (Chinese): |
李革 |
11.
Chinese Character Code as printed on HKID Card: |
|
|
24.
Details of relevant event: |
|
Brief description of relevant event
|
Capacity in which shares were/are held
|
Number of shares bought/sold or involved
|
Currency of transaction |
On Exchange
|
Off Exchange
|
Before relevant event
|
After relevant event
|
Highest price (per share)
|
Average price (per share)
|
Average consideration (per share)
|
Consideration code
|
Long position |
1101 | The number of shares in which you are interested has increased because: you purchased the shares | |
|
2201 | Interest of corporation controlled by you | |
5,235,500 |
HKD |
29.8000 |
28.7123 |
|
|
Short position |
|
|
|
|
|
|
|
|
|
|
|
25.
Total shares in listed corporation immediately before the relevant event: |
| Total number of shares | Percentage figure (%) |
Long position | 584,191,133 | 13.72 |
|
|
26.
Total shares in listed corporation immediately after the relevant event: |
| Total number of shares | Percentage figure (%) |
Long position | 589,426,633 | 13.84 |
|
|
27.
Capacity in which interests disclosed in Box 26 are held: |
Code describing capacity | Number of shares |
2201 | Interest of corporation controlled by you |
| |
|
|
28.
Further information in derivative interests in listed corporation : |
Derivatives code |
Exercise period (dd/mm/yyyy) |
Consideration - if derivatives granted by listed corporation |
Number of shares |
| | Begins | Ends | Currency | Price for grant | Currency | Exercise price | Currency | Price on assignment | |
| | | | | | | | | | |
|
|
29.
Further information in relation to interests of children under 18 and/or spouse: |
Child/Spouse | Name of child/spouse | Number of shares |
| | |
|
|
30.
Further information in relation to interests of corporations controlled by Director: |
Name of controlled corporation | Address and place of incorporation | Name of controlling person | % control | Direct interest (Y/N) | Number of shares |
WuXi Biologics Holdings Limited | Kingston Chambers, PO Box 173, Road Town, Tortola, British Virgin Islands | Ge Li | 55.03 | Y | |
Ge Li & Ning Zhao Family Foundation | 160 Greentree Drive, Suite 101, City of Dover, County of Kent, DE 19904, Delaware | Ge Li | 100.00 | Y | |
|
|
31.
Further information in relation to interests held by Director jointly with another person: |
Name of joint shareholder | Address | Number of shares |
| | |
|
|
32.
Further information from a director who is a trustee, or beneficiary of a trust, or a person who has set up a Discretionary Trust: |
Names of Trust | Address | Status code | Number of shares |
| | | |
|
|
33.
Further information from a party to an agreement under Section 317 (Please see Notes for further information required): |
Names of other parties | Address | Number of shares |
| | |
Total number of shares in which a director is interested under sections 317 and 318 | 589,426,633 |
|
|
34.
Supplementary information: |
Box 33: Mr. Zhaohui Zhang and Mr. Xiaozhong Liu continue to be concerted parties in respect of the 589,426,633 shares of the Company
|
35.
Log/Serial Number of the previous form: |
|
36.
Number of concert party document(s) under section 317 attached/uploaded: |
1
A0000000000001521569.pdf
|
Date of filing this Form 3A: |
25/01/2024 (dd/mm/yyyy)
|
|